Imagen de Portada

Synergistic Antibacterial Activity of Azithromycin-Loaded Chitosan Nanoparticles Alone and in Combination with Cetirizine Dihydrochloride Against Resistant Isolates of Respiratory Tract Infections

Guardado en:
Publicado en:Antibiotics vol. 14, no. 10 (2025), p. 992-1007
Autor principal: Anwar Umbreen
Otros Autores: Sattar Adeel, Rasheed, Muhammad Adil, Shabbir Muhammad Abu Bakr, Mateen, Abbas
Publicado:
MDPI AG
Materias:
Nanoparticles
Klebsiella
Drug resistance
Staphylococcus infections
Antibiotics
Cetirizine
Respiratory tract infection
Antiinfectives and antibacterials
Gentamicin
Chloramphenicol
Nanotechnology
Gene expression
Chitosan
Effectiveness
Drug delivery
Public health
Azithromycin
ErmA gene
Antibiotic resistance
Pathogens
Antibacterial activity
Bacteria
Gram-positive bacteria
Methicillin
Gram-negative bacteria
Chloromycetin
Pneumonia
Cefoxitin
Sputum
Permeability
Nosocomial infections
ErmB gene
Synergistic effect
Respiratory tract
Antimicrobial agents
Acceso en línea:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Resumen:Background/Objectives: Antibiotic resistance is a major public health concern, with considerable socio-economic consequences. Researchers are exploring alternative strategies, including nanotechnology, which has shown significance in targeted drug delivery. This study evaluates the synergistic antibacterial activity of azithromycin-loaded chitosan nanoparticles (AZM-CSNPs) against azithromycin-resistant clinical respiratory isolates of methicillin-resistant Staphylococcus aureus (MRSA) and Klebsiella pneumoniae (K. pneumoniae). Methods: A total of 87 sputum samples (n = 87) were collected and analyzed. The ermB gene for K. pneumoniae and the ermA gene for MRSA were used to confirm resistant isolates. Among 87 samples, 29 manifested K. pneumoniae, and 32 exhibited MRSA-positive cultures, confirmed through phenotypic and genotypic methods. The RT-PCR is performed by using a cDNA Kit to determine the gene expression. Results: The results elucidate resistance of K. pneumoniae against several antibiotics, including azithromycin (15 µg), chloramphenicol (30 µg), and amoxicillin (30 µg), while MRSA also showed resistance to cefoxitin (30 µg), azithromycin (15 µg), and gentamycin (10 µg). Reduction in the MIC value of the nanoparticle formulation showed their effectiveness. The AZM-CSNPs combined with cetirizine dihydrochloride helped to down-regulate the resistant genes. Conclusions: Notably, a strong synergistic effect was observed with AZM-CSNPs in combination with cetirizine, significantly enhancing antibacterial efficacy against resistant isolates.
ISSN:2079-6382
DOI:10.3390/antibiotics14100992
Fuente:Biological Science Database